Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Bronchiolitis Obliterans HELP
Based on 2,128 articles published since 2009
||||

These are the 2128 published articles about Bronchiolitis Obliterans that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. 2014

Meyer, Keith C / Raghu, Ganesh / Verleden, Geert M / Corris, Paul A / Aurora, Paul / Wilson, Kevin C / Brozek, Jan / Glanville, Allan R / Anonymous4900810 / Anonymous4910810. ·School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA kcm@medicine.wisc.edu. · School of Medicine, University of Washington, Seattle, WA, USA. · University of Leuven, Leuven, Belgium. · Freeman Hospital, Newcastle upon Tyne, UK. · Great Ormond Street Hospital for Children, London, UK. · Boston University Medical Center, Boston, MA, USA. · McMaster University, Hamilton, ON, Canada. · The Lung Transplant Unit, St Vincents Hospital, Sydney, Australia. ·Eur Respir J · Pubmed #25359357.

ABSTRACT: Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society convened a committee of international experts to describe and/or provide recommendations for 1) the definition of BOS, 2) the risk factors for developing BOS, 3) the diagnosis of BOS, and 4) the management and prevention of BOS. A pragmatic evidence synthesis was performed to identify all unique citations related to BOS published from 1980 through to March, 2013. The expert committee discussed the available research evidence upon which the updated definition of BOS, identified risk factors and recommendations are based. The committee followed the GRADE (Grading of Recommendation, Assessment, Development and Evaluation) approach to develop specific clinical recommendations. The term BOS should be used to describe a delayed allograft dysfunction with persistent decline in forced expiratory volume in 1 s that is not caused by other known and potentially reversible causes of post-transplant loss of lung function. The committee formulated specific recommendations about the use of systemic corticosteroids, cyclosporine, tacrolimus, azithromycin and about re-transplantation in patients with suspected and confirmed BOS. The diagnosis of BOS requires the careful exclusion of other post-transplant complications that can cause delayed lung allograft dysfunction, and several risk factors have been identified that have a significant association with the onset of BOS. Currently available therapies have not been proven to result in significant benefit in the prevention or treatment of BOS. Adequately designed and executed randomised controlled trials that properly measure and report all patient-important outcomes are needed to identify optimal therapies for established BOS and effective strategies for its prevention.

2 Editorial Bronchiolitis obliterans syndrome 'endotypes' in haematopoietic stem cell transplantation. 2019

Chambers, Daniel C. ·Queensland Lung Transplant Program, The Prince Charles Hospital, Brisbane, QLD, Australia. · School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia. ·Respirology · Pubmed #30730090.

ABSTRACT: -- No abstract --

3 Editorial Freedom from chronic lung allograft dysfunction (CLAD) or CLAD-free survival: What's in a name? 2019

Verleden, Geert M / Verleden, Stijn E / Vos, Robin. ·Lung Transplantation Unit, University Hospital Gasthuisberg, Leuven, Belgium. Electronic address: geert.verleden@uzleuven.be. · Dept Chrometa, Lung Transplantation Unit, Katholieke Universiteit Leuven, Leuven, Belgium. · Lung Transplantation Unit, University Hospital Gasthuisberg, Leuven, Belgium. ·J Heart Lung Transplant · Pubmed #30497817.

ABSTRACT: -- No abstract --

4 Editorial Retransplantation improves survival in pediatric lung transplant recipients. 2018

Hsin, Michael / Cypel, Marcelo. ·Department of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong, China. Electronic address: mkhsin@hotmail.com. · Division of Thoracic Surgery, University of Toronto, Toronto, Ontario, Canada. ·J Thorac Cardiovasc Surg · Pubmed #30336928.

ABSTRACT: -- No abstract --

5 Editorial Lung transplantation and esophageal dysfunction. 2018

Ruiz de León San Juan, Antonio. ·Aparato Digestivo, Hospital Universitario Cínico San Carlos, España. ·Rev Esp Enferm Dig · Pubmed #29807435.

ABSTRACT: Lung transplants belong in the group of organ transplants with poorer outcomes, with acute rejection and bronchiolitis obliterans being cited as major causes of this. Poor allograft evolution has been associated with multiple factors, including those related to esophagogastric disease. In patients with end-stage pulmonary conditions eligible for a lung transplant gastroesophageal reflux (GER), esophageal dysmotily, and gastroparesis are highly prevalent and worsen upon transplantation, which may compromise transplant viability. High-resolution impedance manometry and long-term impedance pH-metry studies provide a new perspective where reflux and dysmotility share the limelight with changes in the diagnostic approach and in potential therapies.

6 Editorial One piece at a time: Making sense of chronic lung allograft dysfunction. 2018

van Berkel, Victor. ·Department of Cardiovascular and Thoracic Surgery, University of Louisville School of Medicine, Louisville, Ky. Electronic address: victor.vanberkel@louisville.edu. ·J Thorac Cardiovasc Surg · Pubmed #29559256.

ABSTRACT: -- No abstract --

7 Editorial Epithelial Progenitor Cells Take Center Stage in Lung Transplantation. 2018

Smirnova, Natalia F / Eickelberg, Oliver. ·1 Division of Pulmonary Sciences and Critical Care Medicine University of Colorado Anschutz Medical Campus, Aurora, Colorado and. · 2 Comprehensive Pneumology Center/Institute of Lung Biology and Disease University Hospital Ludwig Maximilians University and Helmholtz Zentrum München Munich, Germany. ·Am J Respir Crit Care Med · Pubmed #29350973.

ABSTRACT: -- No abstract --

8 Editorial Changing the curve in chronic lung allograft dysfunction: Implications of chronic lung allograft dysfunction phenotypes in assessing treatment interventions. 2018

Mooney, Joshua J. ·Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University, Stanford, California. Electronic address: jjmooney@stanford.edu. ·J Heart Lung Transplant · Pubmed #28720212.

ABSTRACT: -- No abstract --

9 Editorial Chest computed tomography in bronchiolitis obliterans after bone marrow transplantation. 2017

Hochhegger, Bruno / Baldisserotto, Matteo. ·Adjunct Professor of Radiology at the Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil. E-mail: brunohochhegger@gmail.com. · Professor in the Graduate Program of the Faculdade de Medicina da Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brasil. E-mail: matteo.baldisserotto@pucrs.br. ·Radiol Bras · Pubmed #28670041.

ABSTRACT: -- No abstract --

10 Editorial Physiology of chronic lung allograft dysfunction: back to the future? 2017

Glanville, Allan R. ·The Lung Transplant Unit, St. Vincent's Hospital, Sydney, NSW, Australia allan.glanville@svha.org.au. ·Eur Respir J · Pubmed #28404654.

ABSTRACT: -- No abstract --

11 Editorial Necessity is the mother of invention: Alternative techniques in living-related lobar transplantation come to the mainstream. 2017

Walters, Dustin M / Krupnick, Alexander Sasha. ·University of Virginia Lung Transplant Program, Department of Surgery, University of Virginia, Charlottesville, Va. · University of Virginia Lung Transplant Program, Department of Surgery, University of Virginia, Charlottesville, Va. Electronic address: sashak@virginia.edu. ·J Thorac Cardiovasc Surg · Pubmed #27939496.

ABSTRACT: -- No abstract --

12 Editorial Prevention of bronchiolitis obliterans-the realization of a hope? 2017

Cascalho, Marilia. ·Transplantation Section, Surgery Department and Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: marilia@umich.edu. ·J Heart Lung Transplant · Pubmed #27667135.

ABSTRACT: -- No abstract --

13 Editorial Spirometry States the Obvious: Recognizing Bronchiolitis Obliterans Syndrome Early after Hematopoietic Cell Transplantation. 2016

Belloli, Elizabeth A / Lama, Vibha N. ·Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan. ·Ann Am Thorac Soc · Pubmed #27831809.

ABSTRACT: -- No abstract --

14 Editorial Phenotypes of Chronic Lung Allograft Dysfunction: Getting Closer Step by Step? 2016

Verleden, S E / Vanaudenaerde, B M / Vos, R / Verleden, G M. ·Department of Clinical and Experimental Medicine, Laboratory for Respiratory Diseases, Lung Transplantation Unit, Katholieke Universiteit Leuven (University of Leuven), Leuven, Belgium. · Department of Respiratory Diseases, Lung Transplantation Unit, Katholieke Universiteit Leuven (University of Leuven), University Hospitals Leuven, Leuven, Belgium. · Department of Respiratory Diseases, Lung Transplantation Unit, Katholieke Universiteit Leuven (University of Leuven), University Hospitals Leuven, Leuven, Belgium. geert.verleden@uzleuven.be. ·Am J Transplant · Pubmed #27305458.

ABSTRACT: -- No abstract --

15 Editorial Diagnosis and management of bronchiolitis obliterans syndrome following lung or hematopoietic cell transplantation. 2016

Meyer, Keith C. ·a University of Wisconsin Lung Transplant and Advanced Lung Disease Program , Section of Allergy, Pulmonary and Critical Care Medicine. · b Department of Medicine , University of Wisconsin School of Medicine and Public Health , Madison , WI , USA. ·Expert Rev Respir Med · Pubmed #26950825.

ABSTRACT: -- No abstract --

16 Editorial Novel effect of rapamycin on experimental obliterative bronchiolitis. 2016

Walters, Dustin M / Mulligan, Michael S. ·Division of Cardiothoracic Surgery, the University of Washington Medical Center, Seattle, Wash. · Division of Cardiothoracic Surgery, the University of Washington Medical Center, Seattle, Wash. Electronic address: msmmd@u.washington.edu. ·J Thorac Cardiovasc Surg · Pubmed #26806507.

ABSTRACT: -- No abstract --

17 Editorial Editorial Commentary: Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle. 2016

Gardiner, Bradley J / Snydman, David R. ·Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts. ·Clin Infect Dis · Pubmed #26565009.

ABSTRACT: -- No abstract --

18 Editorial Harnessing regulatory B cells to prevent experimental obliterative bronchiolitis. 2016

Jungraithmayr, Wolfgang / Brüstle, Karina / Weder, Walter. ·Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland. Electronic address: wolfgang.jungraithmayr@usz.ch. · Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland. ·J Thorac Cardiovasc Surg · Pubmed #26520010.

ABSTRACT: -- No abstract --

19 Editorial Is bronchiolitis obliterans after hematopoietic stem cell transplantation reversible? 2015

Peters, Steve G. ·1 Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester, Minnesota. ·Am J Respir Crit Care Med · Pubmed #26029830.

ABSTRACT: -- No abstract --

20 Editorial Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases? 2015

Brusselle, Guy G. ·Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium Department of Epidemiology and Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. ·Thorax · Pubmed #25870311.

ABSTRACT: -- No abstract --

21 Editorial Intragraft regulatory T cells and lung transplant outcomes--we are still at square one. 2015

Neujahr, David C. ·Emory University Lung Transplant Program, Atlanta, GA, 303022, USA. dneujah@emory.edu. ·Clin Transplant · Pubmed #25757045.

ABSTRACT: -- No abstract --

22 Editorial What we expected all along: Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplantation! 2015

Benden, Christian. ·Division of Pulmonary Medicine, University Hospital Zurich, Zurich, Switzerland. Electronic address: christian_benden@yahoo.de. ·J Heart Lung Transplant · Pubmed #25727772.

ABSTRACT: -- No abstract --

23 Editorial Dangerous liaisons? Gastroesophageal reflux disease and organizing pneumonia. 2015

Drakopanagiotakis, Fotios. · ·Respiration · Pubmed #25720852.

ABSTRACT: -- No abstract --

24 Editorial New humanized mouse model of bronchiolitis obliterans syndrome. 2015

Anegon, Ignacio. ·1 INSERM UMR 1064-Center for Research in Transplantation and Immunology-ITUN Nantes, France. (ianegon@nantes.inserm.fr). ·Transplantation · Pubmed #25695785.

ABSTRACT: Humanized animals are transplanted with human tissues and cells to study their behavior as they do in the human body. This commentary briefly summarizes the recent developments and discusses the limitations of these humanized animal models.

25 Editorial Matrix metalloproteinases and bronchiolitis obliterans: Wrapping the enigma in a riddle. 2015

Denlinger, Chadrick E. ·Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC. Electronic address: denlinge@musc.edu. ·J Thorac Cardiovasc Surg · Pubmed #25618413.

ABSTRACT: -- No abstract --

Next